Lupiximab 100 mg Injection
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Lupiximab 100 mg Injection

Lupiximab 100 mg Injection

Bevazza 100 mg Injection contains bevacizumab 100 mg, a monoclonal antibody used in cancer treatment. It is used for cancers including colorectal, non-small-cell lung, kidney, ovarian, cervical, and other approved cancers. The medicine is administered as an intravenous infusion by a healthcare professional under medical supervision.

BUY NOW

Category

Bevacizumab works by blocking vascular endothelial growth factor (VEGF), which helps reduce the formation of new blood vessels that supply tumors. It is commonly used with other anticancer medicines according to the specific cancer and prescribed treatment protocol. Blood pressure, urine protein, bleeding, and wound healing may require monitoring during treatment because bevacizumab can cause clinically important adverse effects. The dose and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 25 mg/mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 4 mL

Product Also Known As

Bevazza 100 mg Injection, Bevazza 100mg Injection, Bevazza 100 mg Vial, Bevazza 100mg Vial, Bevacizumab 100 mg Injection, Bevacizumab 100mg Injection, Bevacizumab 100 mg Vial